In conclusion, our findings suggest that αSyn co-pathology, as detected via CSF-based αSyn SAAs, plays a critical role in accelerating Aβ-induced tau pathophysiology and cognitive decline across the AD spectrum. This evidence concerns the gene PCSK1N and Alzheimer disease.